Zinzino reports 15% group revenue growth in August 2026

Zinzino reported preliminary group revenue of SEK 282.2 million for August 2026, up 15% from SEK 245.9 million in the same month a year earlier.

Revenue in the company's sales markets rose 16% to SEK 280.9 million, while external sales from Faun Pharma were SEK 1.3 million, down from SEK 3.4 million. For January through August, group revenue reached SEK 2.46 billion, an increase of 22% from SEK 2.03 billion in the comparable 2025 period.

The regional figures were mixed. North America recorded the strongest reported August increase, up 61% to SEK 63.0 million. Central Europe increased 18% and South and West Europe rose 11%. The Nordics, Eastern Europe and the Baltics declined for the month.

The figures are preliminary and come from Zinzino's investor-relations release dated September 3, 2026. They should not be treated as audited annual revenue or compared directly with MLMGlobe's FY2025 Global Revenue ranking, which uses approved annual records under a separate methodology.